General Information of the Protein
Protein ID
PT02377
Protein Name
Beta-adrenergic receptor kinase 1
Secondarily
Protein Name
G-protein coupled receptor kinase 2
Gene Name
GRK2
Secondarily
Gene Name
ADRBK1
BARK
BARK1
Sequence
MADLEAVLADVSYLMAMEKSKATPAARASKKILLPEPSIRSVMQKYLEDRGEVTFEKIFSQKLGYLLFRDFCLNHLEEARPLVEFYEEIKKYEKLETEEERVARSREIFDSYIMKELLACSHPFSKSATEHVQGHLGKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQELYRNFPLTISERWQQEVAETVFDTINAETDRLEARKKAKNKQLGHEEDYALGKDCIMHGYMSKMGNPFLTQWQRRYFYLFPNRLEWRGEGEAPQSLLTMEEIQSVEETQIKERKCLLLKIRGGKQFILQCDSDPELVQWKKELRDAYREAQQLVQRVPKMKNKPRSPVVELSKVPLVQRGSANGL
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Kinase
>
Protein Kinase
>
AGC protein kinase group
>
AGC protein kinase GRK family
>
AGC protein kinase BARK subfamily
Function
Specifically phosphorylates the agonist-occupied form of the beta-adrenergic and closely related receptors, probably inducing a desensitization of them (PubMed:19715378). Key regulator of LPAR1 signaling (PubMed:19306925). Competes with RALA for binding to LPAR1 thus affecting the signaling properties of the receptor (PubMed:19306925). Desensitizes LPAR1 and LPAR2 in a phosphorylation-independent manner (PubMed:19306925). Positively regulates ciliary smoothened (SMO)-dependent Hedgehog (Hh) signaling pathway by facilitating the trafficking of SMO into the cilium and the stimulation of SMO activity (By similarity). Inhibits relaxation of airway smooth muscle in response to blue light (PubMed:30284927).
    Show/Hide
Uniprot ID
Primary ID:
P25098

Secondarily ID:
B0ZBE1
Q13837
Q6GTT3
    Show/Hide
Ensembl ID
ENSG00000173020
HGNC ID
HGNC:289
Subcellular Location
Cytoplasm
Cell membrane
Postsynapse
Presynapse
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000023 , BTI-Tn-5B1-4
Compound ID Compound Name Compound Formula
CP0113029
N-[(2,6-difluorophenyl)methyl]-3-[(4-propyl-5-pyrimidin-4-yl-1,2,4-triazol-3-yl)methylamino]benzamide
   Show/Hide
C24H23F2N7O
 1
1
IC50 = 20 nM
   TI
   LI
   LO
   TS
CP0112012
4-[4-fluoro-3-[(2-methoxyphenyl)methylcarbamoyl]phenyl]-N-(1H-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxamide
   Show/Hide
C28H25FN6O4
 1
1
IC50 = 60 nM
   TI
   LI
   LO
   TS
CP0111456
4-[3-[(2,6-dimethylphenyl)methylcarbamoyl]-4-fluorophenyl]-N-(1H-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxamide
   Show/Hide
C29H27FN6O3
 1
1
IC50 = 70 nM
   TI
   LI
   LO
   TS
CP0061504
4-[3-[(2,6-dimethoxyphenyl)methylcarbamoyl]-4-fluorophenyl]-N-(1H-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxamide
   Show/Hide
C29H27FN6O5
 1
1
IC50 = 130 nM
   TI
   LI
   LO
   TS
CP0279940
4-[3-[(2,6-dichlorophenyl)methylcarbamoyl]-4-fluorophenyl]-N-(1H-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxamide
   Show/Hide
C27H21Cl2FN6O3
 1
1
IC50 = 130 nM
   TI
   LI
   LO
   TS
CP0054841
4-[4-fluoro-3-(pyridin-2-ylmethylcarbamoyl)phenyl]-N-(1H-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxamide
   Show/Hide
C26H22FN7O3
 1
1
IC50 = 150 nM
   TI
   LI
   LO
   TS
CP0061404
4-[4-fluoro-3-[(3-fluorophenyl)methylcarbamoyl]phenyl]-N-(1H-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxamide
   Show/Hide
C27H22F2N6O3
 1
1
IC50 = 200 nM
   TI
   LI
   LO
   TS
CP0279933
4-[3-[(2,6-difluorophenyl)methylcarbamoyl]-4-fluorophenyl]-N-(1H-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxamide
   Show/Hide
C27H21F3N6O3
 1
1
IC50 = 220 nM
   TI
   LI
   LO
   TS
CP0061490
4-[3-[2-(2,6-dimethylphenyl)ethylcarbamoyl]-4-fluorophenyl]-N-(1H-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxamide
   Show/Hide
C30H29FN6O3
 1
1
IC50 = 230 nM
   TI
   LI
   LO
   TS
CP0174820
4-[4-fluoro-3-(isoquinolin-1-ylmethylcarbamoyl)phenyl]-N-(1H-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxamide
   Show/Hide
C30H24FN7O3
 1
1
IC50 = 280 nM
   TI
   LI
   LO
   TS
CP0257052
4-[4-fluoro-3-(2-pyridin-2-ylethylcarbamoyl)phenyl]-N-(1H-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxamide
   Show/Hide
C27H24FN7O3
 1
1
IC50 = 280 nM
   TI
   LI
   LO
   TS
CP0214468
4-[4-fluoro-3-[(3-methoxyphenyl)methylcarbamoyl]phenyl]-N-(1H-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxamide
   Show/Hide
C28H25FN6O4
 1
1
IC50 = 420 nM
   TI
   LI
   LO
   TS
CP0061500
4-[3-[2-[(2,6-dimethoxyphenyl)methylamino]-2-oxoethyl]-4-fluorophenyl]-N-(1H-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxamide
   Show/Hide
C30H29FN6O5
 1
1
IC50 = 450 nM
   TI
   LI
   LO
   TS
CP0191979
4-[4-fluoro-3-[(4-methoxyphenyl)methylcarbamoyl]phenyl]-N-(1H-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxamide
   Show/Hide
C28H25FN6O4
 1
1
IC50 = 460 nM
   TI
   LI
   LO
   TS
CP0112011
4-[3-(benzylcarbamoyl)-4-fluorophenyl]-N-(1H-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxamide
   Show/Hide
C27H23FN6O3
 1
1
IC50 = 690 nM
   TI
   LI
   LO
   TS
CP0025658
GSK-180736A
   Show/Hide
C19H16FN5O2
 1
1
IC50 = 770 nM
   TI
   LI
   LO
   TS
CP0075077
4-[3-[[2,6-bis(trifluoromethyl)phenyl]methylcarbamoyl]-4-fluorophenyl]-N-(1H-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxamide
   Show/Hide
C29H21F7N6O3
 1
1
IC50 = 1200 nM
   TI
   LI
   LO
   TS
CP0046806
(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine
   Show/Hide
C19H20FNO3
 1
1
IC50 = 1380 nM
   TI
   LI
   LO
   TS
CP0090326
4-[4-fluoro-3-[(3-methylpyridin-2-yl)methylcarbamoyl]phenyl]-N-(1H-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxamide
   Show/Hide
C27H24FN7O3
 1
1
IC50 = 1900 nM
   TI
   LI
   LO
   TS
CP0182293
4-[3-[[3,5-bis(trifluoromethyl)phenyl]methylcarbamoyl]-4-fluorophenyl]-N-(1H-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxamide
   Show/Hide
C29H21F7N6O3
 1
1
IC50 = 2700 nM
   TI
   LI
   LO
   TS
CP0455945
4-[4-fluoro-3-(methylcarbamoyl)phenyl]-N-(1H-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxamide
   Show/Hide
C21H19FN6O3
 1
1
IC50 = 4300 nM
   TI
   LI
   LO
   TS
CP0054840
4-[3-[(2,6-dimethylphenyl)methylcarbamoyl]-4-fluorophenyl]-N-(1H-indazol-5-yl)-N,6-dimethyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxamide
   Show/Hide
C30H29FN6O3
 1
1
IC50 = 4600 nM
   TI
   LI
   LO
   TS
CP0174819
4-[4-fluoro-3-(2-pyridin-4-ylethylcarbamoyl)phenyl]-N-(1H-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxamide
   Show/Hide
C27H24FN7O3
 1
1
IC50 = 4800 nM
   TI
   LI
   LO
   TS
CP0279937
2-fluoro-5-[5-(1H-indazol-5-ylcarbamoyl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidin-4-yl]benzoic acid
   Show/Hide
C20H16FN5O4
 1
1
IC50 = 20000 nM
   TI
   LI
   LO
   TS
CP0279934
4-[3-[2-[(2,6-dimethylphenyl)methylamino]-2-oxoethyl]-4-fluorophenyl]-N-(1H-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxamide
   Show/Hide
C30H29FN6O3
 1
1
IC50 = 25000 nM
   TI
   LI
   LO
   TS
CP0061497
4-[3-[2-[[2,6-bis(trifluoromethyl)phenyl]methylamino]-2-oxoethyl]-4-fluorophenyl]-N-(1H-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxamide
   Show/Hide
C30H23F7N6O3
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0113033
N-(1,3-benzodioxol-5-yl)-4-[4-fluoro-3-(pyridin-2-ylmethylcarbamoyl)phenyl]-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxamide
   Show/Hide
C26H22FN5O5
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0113029
N-[(2,6-difluorophenyl)methyl]-3-[(4-propyl-5-pyrimidin-4-yl-1,2,4-triazol-3-yl)methylamino]benzamide
   Show/Hide
C24H23F2N7O
 2
1 IC50 = 20 nM
2 Kd = 1.99 nM
CP0235953
3-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)methylamino]-N-[[2-(trifluoromethyl)phenyl]methyl]benzamide
   Show/Hide
C24H21F3N6O
 1
1 IC50 = 30 nM
CP0061504
4-[3-[(2,6-dimethoxyphenyl)methylcarbamoyl]-4-fluorophenyl]-N-(1H-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxamide
   Show/Hide
C29H27FN6O5
 1
1 IC50 = 130 nM
CP0025658
GSK-180736A
   Show/Hide
C19H16FN5O2
 1
1 IC50 = 770 nM
CP0046806
(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine
   Show/Hide
C19H20FNO3
 3
1 IC50 = 1100 nM
2 IC50 = 1380 nM
3 Kd = 2980 nM
CP0705316
3-{[1-Pyridin-4-yl-meth-(E)-ylidene-hydrazinocarbonylmethyl]-amino}-benzamide
   Show/Hide
C15H15N5O2
 1
1 Ki = 10 nM
Clinical Information about the Protein
Target 1 ( Beta-adrenergic receptor kinase 1 (ADRBK1) )
Target Type Patented-recorded Target